AZN
Price
$76.01
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
14 days until earnings call
PFE
Price
$28.86
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Earnings call today
Ad is loading...

AZN vs PFE

Header iconAZN vs PFE Comparison
Open Charts AZN vs PFEBanner chart's image
AstraZeneca
Price$76.01
Change-$0.00 (-0.00%)
Volume$5.07M
CapitalizationN/A
Pfizer
Price$28.86
Change-$0.00 (-0.00%)
Volume$37.92M
CapitalizationN/A
View a ticker or compare two or three
AZN vs PFE Comparison Chart
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AZN vs. PFE commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a StrongBuy and PFE is a Hold.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (AZN: $75.99 vs. PFE: $28.86)
Brand notoriety: AZN and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 127% vs. PFE: 119%
Market capitalization -- AZN: $208.98B vs. PFE: $157.14B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 2 FA rating(s) are green whilePFE’s FA Score has 2 green FA rating(s).

  • AZN’s FA Score: 2 green, 3 red.
  • PFE’s FA Score: 2 green, 3 red.
According to our system of comparison, AZN is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 4 TA indicator(s) are bullish while PFE’s TA Score has 3 bullish TA indicator(s).

  • AZN’s TA Score: 4 bullish, 4 bearish.
  • PFE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AZN is a better buy in the short-term than PFE.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а -1.87% price change this week, while PFE (@Pharmaceuticals: Major) price change was -0.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

AZN is expected to report earnings on Feb 06, 2025.

PFE is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($209B) has a higher market cap than PFE($157B). PFE has higher P/E ratio than AZN: PFE (74.92) vs AZN (35.30). AZN YTD gains are higher at: 15.266 vs. PFE (4.744). AZN has higher annual earnings (EBITDA): 13.4B vs. PFE (9.56B). PFE has more cash in the bank: 12.7B vs. AZN (5.86B). AZN has less debt than PFE: AZN (28.6B) vs PFE (70.8B). PFE has higher revenues than AZN: PFE (58.5B) vs AZN (45.8B).
AZNPFEAZN / PFE
Capitalization209B157B133%
EBITDA13.4B9.56B140%
Gain YTD15.2664.744322%
P/E Ratio35.3074.9247%
Revenue45.8B58.5B78%
Total Cash5.86B12.7B46%
Total Debt28.6B70.8B40%
FUNDAMENTALS RATINGS
AZN vs PFE: Fundamental Ratings
AZN
PFE
OUTLOOK RATING
1..100
6858
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
1193
SMR RATING
1..100
5490
PRICE GROWTH RATING
1..100
5657
P/E GROWTH RATING
1..100
541
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (4) in the Pharmaceuticals Major industry is in the same range as AZN (23). This means that PFE’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (11) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (93). This means that AZN’s stock grew significantly faster than PFE’s over the last 12 months.

AZN's SMR Rating (54) in the Pharmaceuticals Major industry is somewhat better than the same rating for PFE (90). This means that AZN’s stock grew somewhat faster than PFE’s over the last 12 months.

AZN's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as PFE (57). This means that AZN’s stock grew similarly to PFE’s over the last 12 months.

PFE's P/E Growth Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for AZN (54). This means that PFE’s stock grew somewhat faster than AZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNPFE
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 16 days ago
56%
Bullish Trend 14 days ago
56%
Declines
ODDS (%)
Bearish Trend 5 days ago
44%
Bearish Trend 5 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 7 days ago
34%
View a ticker or compare two or three
Ad is loading...
AZN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with JNJ. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+1.44%
JNJ - PFE
45%
Loosely correlated
+0.45%
BMY - PFE
37%
Loosely correlated
+1.39%
BIIB - PFE
29%
Poorly correlated
+1.83%
OGN - PFE
27%
Poorly correlated
+1.75%
AMGN - PFE
27%
Poorly correlated
+0.06%
More